Begrivac 2010/2011 Injektionsvätska, suspension

Country: Շվեդիա

language: շվեդերեն

source: Läkemedelsverket (Medical Products Agency)

active_ingredient:

influensavirus A/California/7/2009 (H1N1)-deriverad stam (NYMC X-181), spjälkat virus, inaktiverat; influensavirus A/Perth/16/2009 (H3N2)-liknande stam (NYMC X-187, deriverad från A/Victoria/210/2009), spjälkat virus, inaktiverat; influensavirus B/Brisbane/60/2008-liknande stam (B/Brisbane/60/2008), ytantigen, inaktiverat

MAH:

Novartis Vaccines and Diagnostics GmbH

ATC_code:

J07BB02

INN:

the influenza virus A/California/7/2009 (H1N1)-derived strain (NYMC X-181), spjälkat virus, inactivated; influenza virus, A/Perth/16/2009 (H3N2)-like strain (NYMC X-187, derived from A/Victoria/210/2009), spjälkat virus, inactivated; influenza virus, B/Brisbane/60/2008-like strain (B/Brisbane/60/2008), the surface antigen, inactivated

pharmaceutical_form:

Injektionsvätska, suspension

composition:

influensavirus B/Brisbane/60/2008-liknande stam (B/Brisbane/60/2008), ytantigen, inaktiverat 15 mikrog Aktiv substans; influensavirus A/Perth/16/2009 (H3N2)-liknande stam (NYMC X-187, deriverad från A/Victoria/210/2009), spjälkat virus, inaktiverat 15 mikrog Aktiv substans; influensavirus A/California/7/2009 (H1N1)-deriverad stam (NYMC X-181), spjälkat virus, inaktiverat 15 mikrog Aktiv substans

prescription_type:

Receptbelagt

therapeutic_area:

spjälkat virus eller ytantigen

authorization_status:

Avregistrerad

authorization_date:

1998-05-29